FDA
-
-
-
-
-
-
-
BioLife Solutions Reports Second Quarter 2022 Financial Results and Updates Full Year 2022 Revenue Guidance
-
-
-
-
-
-
-
Sexton Biotechnologies to be Acquired by Biolife Solutions
-
-
-
-
-
-
-
BioLife Solutions (BLFS) Tops Q4 EPS by 1c, Revenues Beat
-
-
-
-
-
-
-
BioLife Solutions Announces Third Quarter 2019 Financial Results
-
-
-
-
-
-
-
New Policies to Advance Development of Cell and Gene Therapies Announced by FDA
-
-
-
-
-
-
-
BioLife Solutions Executes 10 Year Supply Agreement with TissueGene for CryoStor® Use in Invossa™ Osteoarthritis Cell-Mediated Gene Therapy
251,651 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All